that VMinhibits protein synthesis was first shown in intact Mycobacterium aviurrP and it is a ribosomal inhibitor since VM resistance of certain mutants of Mycobacterium smegmatis and Mycobacterium tuberculosis can be attributed to an alteration of ribosomes4~7). The characteristics of VMbinding to ribosomes have been studied.
The drug reduced the amounts of [3H]dihydrostreptomycin bound to ribosomes of M. smegmatis and Escherichia coli suggesting an interaction between the binding sites of these antibiotics8).
[14C]Tuberactinomycin O (TMO), VM derivative, bound to ribosomal RNAbut not to ribosomal protein and blocked the in vitro assembly of E. coli 50S subunits9).
[14C]TMO bound to both E. coli 30S
and 50S subunits9>10). The strong binding of [14C]TMO to M. smegmatis 70S ribosomes and its weak affinity to either isolated subunits from M. smegmatis or 70S ribosomes from E: coli or VM-resistant M. smegmatis suggested the inhibitory effects of the drug are due to the association of VM-susceptible mycobacterial subunits resulting in potent inhibition of polypeptide synthesis in Mycobacterium1^.
Therefore, the drug probably influences functions in which both ribosomal subunits are involved. Such functions are 1) dissociation and association, 2) peptidyl tRNA binding to the P site and the A site, and 3) translocation. These possibilities were examined with the conclusion that VM inhibits dissociation of ribosomes. This effect of the drug was not seen with VMresistant M. smegmatisribosomes12).
Since higher concentrations of VMinhibited poly(U)-directed polyphenylalanine synthesis in a E. coli cell-free system13)9 detailed studies of the effect of VMon elongation steps were per-1277 formed in this system.
No induction of misreading by VMhas been reported13 >14) , while the induction of the misreading at high VMconcentrations was reported15'1*0. This antibiotic was reported to prevent both the binding of fMet-tRNA to the ribosomes and the translocation reaction in elongation processes in polypeptide synthesis17), and has been confirmed by other groups18>1Q\ I examine the effect of VMon elongation in E. coli cell-free translation system; I conclude that VM influence not only the translocation but also binding to the A site.
E. coli strain A19 was used in this study. Poly (U) and Table 1 . The binding at the P site was not influenced significantly, whereas binding at the A site condition was reduced. In the P site reaction, 86% of the bound Ac-[14C]Phe-tRNAplie reacted with puromycin indicating the binding to the P site was near quantitative. At the A site puromycin reaction was seen only after incubation with EF-G to allow translocation, indicating the binding at the A site. Therefore, it can be concluded that YMaffects the binding affinity of Ac-[14C]-Phe-tRNAplie to the A site but not to the P site of the ribosome.
The peptidyl transferase reaction was examined by measuring the puromycin reaction at the P site. The maximumactivity, 5,310 counts, was obtained, when EF-G was added. As indicated above the efficiency of the peptidyl transferase reaction was 86%. The puromycin reaction in the presence of the drug was only slightly affected. The translocation reaction can be examined by the difference in the puromycin reaction in the presence and absence of EF-G. The results obtained in the presence of 7^m VMare shown in Table 1 . The effects of varying VMconcentration on binding to the P site and the A site, the puromycin reaction and translocation, is presented in Table 1 . Binding at the P site and the peptidyl transferase reaction were not affected significantly by VM, whereas the binding to the A site and the translocation reaction was inhibited by 
